Resolution: standard / high
Figure 4.
Changes in atherogenic to anti-atherogenic particle ratio (LDL-P/HDL-P). Simvastatin but not fenofibrate reduce the LDL-P/HDL-P ratio significantly. * p < 0.05 vs baseline.
Chan et al. BMC Clinical Pharmacology 2008 8:10 doi:10.1186/1472-6904-8-10
Download authors' original image
